EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 4.0

Therapeutic apartheid: a cross-sectional assessment of estimated cost, accessibility, affordability, and availability among psychotropic medications across 25 regions

Javier A Flores-Cohaila, Luis Arturo Vílchez Salcedo, Carlos Alexis Salgado Valenzuela, Cesar Li Amenero, Jose Carlos Bojórquez-De la Torre, Ana Maria Zamalloa-Torres, Brayan Miranda-Chavez, Jeff Huarcaya-Victoria, Cesar Copaja-Corzo iD

Therapeutic Advances in Psychopharmacology · 2026-08 · 16

DOI: 10.1177/20451253261440374 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 16.08.2026. Verfasst von Javier A Flores-Cohaila und 8 weiteren Autor:innen. Beteiligte Einrichtung: Grupo NEMECS: Neurociencias, Metabolismo, Efectividad Clínica y Sanitaria, Universidad Científica del Sur, Carrera de Medicina Humana, Lima, Perú. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mental disorders affect approximately 20% of the global population and remain a leading cause of disability and premature mortality. Despite pharmacotherapy being central to treatment, access to psychotropic medicines is highly unequal, particularly in low- and middle-income countries. In South America, comprehensive national evaluations integrating availability, price, affordability, and geographic accessibility are scarce.

Objective

To assess the availability, cost, affordability, and geographic accessibility of psychotropic medicines across public and private sectors in all regions of Peru.

Design

A secondary cross-sectional analytical study.

Methods

We use open-access data from the Peruvian Observatory of Pharmaceutical Products between May 20 and 25, 2025. A total of 54 psychotropic medicines were included based on the WHO and national essential medicine lists and expert consensus. Outcomes included median unit cost (interquartile range), availability (% of facilities), affordability (days of minimum wage for a 30-day treatment), and regional accessibility. Public–private cost differences were assessed using Wilcoxon rank-sum tests and Cliff’s Delta.

Results

Only 22.2% of psychotropics were classified as essential by both WHO and national criteria. Median costs were substantially higher in the private sector, with price differences ranging from 2- to 140-fold (e.g., risperidone 2 mg: $1.41 private vs $0.01 public; Cliff’s Delta = 0.99). While essential medicines were generally affordable in the public sector (

Schlagwörter

Stichwörter der Autor:innen

Peruhealth equitymental health disparitiespharmaceutical policypsychotropic medication access

Autor:innen und Institutionen

  • Grupo NEMECS: Neurociencias, Metabolismo, Efectividad Clínica y Sanitaria, Universidad Científica del Sur, Carrera de Medicina Humana, Lima, Perú.
  • Departamento de Psiquiatría, Hospital Víctor Larco Herrera, Magdalena del Mar, Lima, Perú.
  • Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Perú.
  • Grupo de Estudios e Investigación en Educación Médica y Bioética de la FACSA, EDUCAB - UPT, Universidad Privada de Tacna, Tacna, Perú.
  • Servicio de Geriatría, Hospital Nacional Guillermo Almenara Irigoyen, Essalud, Lima, Perú.
  • Escuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Ica, Perú.

ORCID-Profile: Cesar Copaja-Corzo

Zitieren

APA

Flores-Cohaila, J. A., Vílchez Salcedo, L. A., Salgado Valenzuela, C. A., Li Amenero, C., Carlos Bojórquez-De la Torre, J., Zamalloa-Torres, A. M., Miranda-Chavez, B., Huarcaya-Victoria, J., & Copaja-Corzo, C. (2026). Therapeutic apartheid: a cross-sectional assessment of estimated cost, accessibility, affordability, and availability among psychotropic medications across 25 regions. Therapeutic Advances in Psychopharmacology, 16. https://doi.org/10.1177/20451253261440374

Vancouver

Flores-Cohaila JA, Vílchez Salcedo LA, Salgado Valenzuela CA, Li Amenero C, Carlos Bojórquez-De la Torre J, Zamalloa-Torres AM, et al. Therapeutic apartheid: a cross-sectional assessment of estimated cost, accessibility, affordability, and availability among psychotropic medications across 25 regions. Therapeutic Advances in Psychopharmacology. 2026;16. doi:10.1177/20451253261440374

BibTeX
@article{FloresCohaila2026,
  author = {Flores-Cohaila, Javier A and Vílchez Salcedo, Luis Arturo and Salgado Valenzuela, Carlos Alexis and Li Amenero, Cesar and Carlos Bojórquez-De la Torre, Jose and Zamalloa-Torres, Ana Maria and Miranda-Chavez, Brayan and Huarcaya-Victoria, Jeff and Copaja-Corzo, Cesar},
  title = {Therapeutic apartheid: a cross-sectional assessment of estimated cost, accessibility, affordability, and availability among psychotropic medications across 25 regions},
  journal = {Therapeutic Advances in Psychopharmacology},
  year = {2026},
  volume = {16},
  doi = {10.1177/20451253261440374}
}
Kostenlos starten →